The Judicial Health Care Does Not Know How They Choose Drug Providers
<p>The Auditor General's Office was unable to understand the criteria applied in hiring, because there are no documents which show those decisions, and purchases of goods are not justified. Several areas lack an appropriate file, so "the only valid instrument to control" disappears.</p>
A report from the General Audit Office (AGN, for its acronym in Spanish) states that "with few exceptions, they can not discern the criterion for selecting suppliers" of goods and drugs of the Health Care of the Federal Justice System (OSPJN, for its acronym in Spanish).
The inspection body reached that conclusion after detecting that the awards are not settled in any document or administrative act, and that the levels of competition, that is, who should authorize hiring and to what amount, "are not formally defined."
The Health Care of the Judicial Branch delivers supplies and medicines to their members, with total or partial subsidy, through its pharmacy and through private centers. According to OSPJN, buying goods emerge from the monitoring and control of the average demand versus capacity of existing stock. But, beyond the criteria for choosing suppliers, the audit says there are no documents where the stock level justified orders. Also, no papers argue the need to purchase drugs that are not in stock.
On the other hand, the AGN warns that in several areas of the Welfare system files and papers are inadequate, "so the only valid instrument for control over the quality of management disappears," adds the Report adopted in May of this year.
